04 Feb [Infographic] ASCO Names CAR-T Cell Immunotherapy Clinical Cancer Advance of the Year 2017
CAR T-Cell Immunotherapy has been named Advance of the Year in Annual ASCO Report. Cancer experts looking back over the past 12 months have highlighted adoptive immunotherapy with chimeric antigen receptor (CAR) T cells as the most important clinical cancer advance of the year. Released in...